What Dalgety does

Dalgety Limited is a UK-based licensed medical cannabis cultivator and manufacturer headquartered at East Midlands Airport in Castle Donington, Derbyshire. The company operates a single 30,000 square foot EU-GMP certified indoor hydroponic facility — self-described as the only UK facility licensed to cultivate, manufacture, and supply GMP-certified medical cannabis. Dalgety produces pharmaceutical-grade dried cannabis flower for prescription use by UK patients with conditions where conventional treatments have proven inadequate, supplying through B2B distribution partnerships with Curaleaf Laboratories and Grow Pharma.

The cultivation platform combines an AI-controlled environmental monitoring system that regulates lighting, irrigation, humidity, and temperature with a systematic pheno-hunting programme and slow-curing post-harvest process. This stack delivers batch-to-batch consistency within ±10% of stated cannabinoid label values and compliance with European and British Pharmacopoeia standards. Product offerings include the High Society phenotype collection (Oracle, Heritage, Alchemy), Marshmallow OG (Chem MOG expression), and additional cultivars in development. The company markets itself as a domestic UK alternative to imported cannabis-based medicinal products, citing reduced lead times, full traceability, and avoidance of per-shipment MHRA and Home Office import licensing burdens.

Dalgety's go-to-market is enterprise B2B field sales targeting UK healthcare professionals, specialist prescribers, and clinical institutions, supported by a Knowledge Hub of educational content, a Medical Cannabis Clinicians Society partnership for CPD-accredited prescriber training, and active conference participation. Revenue is generated from one-time wholesale sales of EU-GMP certified cannabis flower to clinics, pharmacies, and distribution partners; pricing is not publicly disclosed. The company shipped its first commercial product in March 2025 and announced an £8M expansion drive in June 2025 to add cultivation rooms and introduce extraction capabilities.

Name

Dalgety

Legal name

Dalgety Limited

Website

https://dalgetyuk.co.uk

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Dalgety is a UK-licensed cultivator and manufacturer of pharmaceutical-grade medical cannabis, operating an EU-GMP certified, AI-controlled indoor hydroponic facility at East Midlands Airport and supplying UK prescribers through Curaleaf and Grow Pharma.

Ownership category

akta.pro rank

Headquarters

HQ city

Castle Donington

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Cannabis Cultivation and Supply: Dalgety cultivates, harvests, dries, cures, and supplies EU-GMP certified medical cannabis flower to the UK medical community through distribution partners. Revenue is generated from the sale of pharmaceutical-grade cannabis products to clinics, pharmacies, and patients via prescription pathways.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

Dalgety operates the only UK facility licensed to cultivate, manufacture, and supply EU-GMP certified pharmaceutical-grade medical cannabis flower. The company runs a 30,000 square foot indoor hydroponic facility with AI-controlled environmental systems, producing dried cannabis flower with consistent THC, CBD, and cannabinoid profiles for prescription use by UK patients via clinics, pharmacies, and pharmaceutical distribution partners.

Product overview

Dalgety is a UK-based medical cannabis producer operating a single 30,000 square foot EU-GMP certified indoor hydroponic facility with AI-controlled cultivation systems. The company's product portfolio includes branded medical cannabis flower products such as Marshmallow OG (including Chem MOG phenotype), and the High Society Phenotype Collection (Oracle, Heritage, and Alchemy). Dalgety also offers related services including medically-certified cultivation, product development partnerships with pharmaceutical manufacturers, large-scale distribution through distribution partners, and regulatory compliance support. The company operates an end-to-end controlled process from cultivation through drying, curing, and product development, with distribution facilitated through partnerships with Curaleaf Labs for UK manufacturing and distribution to clinics.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis Flower Products EU-GMP certified dried cannabis flower for medical use, produced in Dalgety's 30,000 square foot UK facility with AI-controlled cultivation systems ensuring consistent THC, CBD and other cannabinoid levels. Sold to UK clinics, pharmacies, and pharmaceutical distributors for use in prescription medicines.
• High Society Phenotype Collection Medical cannabis phenotype collection including High Society: Oracle, High Society: Heritage, and High Society: Alchemy — distinct medical cultivars developed through systematic pheno-hunting for consistent medical use.
• Marshmallow OG Medical cannabis cultivar with Chem Dog lineage, available in Chem MOG phenotype expression. Part of Dalgety's branded medical cannabis portfolio for prescription use.
• Medically-Certified Cultivation Services Advanced cannabis cultivation services compliant with EU GMP standards, featuring AI-controlled indoor hydroponic systems across a 30,000 square foot purpose-built facility, offered to pharmaceutical partners requiring compliant cultivation capacity.
• Product Development Services Partnership with pharmaceutical manufacturers to develop cannabis-based medicinal products addressing specific patient needs, from cultivation through to finished pharmaceutical forms.
• Medical Cannabis Distribution Large-scale distribution of GMP-certified medical cannabis products through established distribution partners to clinics, pharmacies and patients.

Quantifiable outcome

• Consistent cannabinoid profiles within ±10% of stated label value
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Curaleaf LaboratoriescoreChannel Partner/ Reseller/ DistributorDalgety and Curaleaf formed a strategic domestic supply chain partnership for the UK medical cannabis market. Dalgety's EU-GMP certified cultivation and pharmaceutical-grade production feeds into Curaleaf Labs' UK manufacturing, testing, and batch release. Curaleaf distributes finished patient prescription packs through its network of clinics, wholesalers and pharmacies. This partnership creates end-to-end UK alignment with clear MHRA/Home Office visibility from seed to sealed pack.
• Grow PharmacoreChannel Partner/ Reseller/ DistributorDalgety partners with Grow Pharma to supply UK-grown medical cannabis products to the pharmaceutical market. Prof. Mike Barnes (Chair of MCCS) and Grow Pharma CEO Pierre van Weperen welcomed Dalgety as a supplier of high-quality medical cannabis to the UK prescription market, noting the collaboration brings UK-grown medicines with industry-leading expertise to patients.
• Medical Cannabis Clinicians Society (MCCS)coreStrategic or Co-development PartnerCuraleaf Laboratories formalised a partnership with MCCS enabling the society to leverage Curaleaf's resources to deliver CPD-accredited education and shape a central source of information for UK prescribers. MCCS also works to improve access to education on medical cannabis and the endocannabinoid system for doctors, medical students, and allied healthcare professionals. Dr. Rowan Thompson, Vice Chair of MCCS, has contributed educational content featured on Dalgety's platform.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Regional players

• EMMAC Life Sciences (SOMAI Pharmaceuticals): European medical cannabis group with UK and EU cultivation and distribution operations. Comparable as a regional peer competing for European medical cannabis market share with GMP-certified production.

Broad incumbents

• Curaleaf International: UK-based arm of Curaleaf Holdings operating manufacturing and distribution for medical cannabis across Europe. Directly comparable as Dalgety's distribution partner and as a competing integrated producer/distributor in the UK market.
• Aurora Cannabis: Canadian-licensed producer with European medical cannabis distribution, including into the UK. Comparable as a competing imported CBPM supplier where Dalgety's domestic positioning is a deliberate differentiator.
• Canopy Growth Corporation: Global cannabis company with medical cannabis operations across multiple jurisdictions including Europe. Comparable as a competing GMP-certified medical cannabis brand serving similar patient populations.
• GW Pharmaceuticals (Jazz Pharmaceuticals): UK pioneer of cannabinoid medicines (Sativex, Epidyolex) and the established broad incumbent in the UK/European medical cannabis space. Relevant as the category leader Dalgety is positioned against in cannabinoid-based prescriptions.
• Tilray Brands: Global medical and recreational cannabis producer with established UK/European medical cannabis operations. Comparable as a large-scale GMP-certified competitor supplying CBPMs into the same UK prescription channel.

Emerging players

• Oxford Cannabinoid Technologies: UK-based cannabinoid therapeutics company in clinical-stage development. Comparable as a UK-focused emerging player in the medical cannabis value chain with overlapping end-patient focus.
• Khiron Life Sciences: Medical cannabis company with European operations supplying CBPMs into the UK and EU. Comparable as a smaller international player competing in the same medical cannabis prescription channel as Dalgety.

Direct peers

• Celadon Pharmaceuticals: UK-licensed medical cannabis cultivator focused on pharmaceutical-grade cannabis for the UK prescription market. Directly comparable as a UK GMP-certified cannabis producer targeting the same prescriber and patient base as Dalgety.
• Grow Pharma: UK medical cannabis distributor and supplier serving clinics and pharmacies with CBPMs. Comparable as a channel counterpart that competes for and distributes competing UK and imported medical cannabis products.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/dalgety_mc
• Facebookfacebook.com/profile.php?id=61569282431563
• LinkedInlinkedin.com/company/dalgety-ltd
• Instagraminstagram.com/dalgetyuk

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dalgety